Is Kyndryl Holdings KD stock forming a breakout pattern Q1 2026 EPS Misses Estimates Bristol Myers Squibb BMY Valuation Deep Dive Assessing If The LargeCap Pharma Name Is The Best Bargain In Big Pharma OKUR OnKure Therapeutics reports narrower Q4 2025 loss than estimates shares drop 204 percent in trading